• Careers
  • Events
  • Library
  • News
Veristat_logo_tm
  • Why Veristat
    • About Us
    • Our Approach
    • Press
    • Corporate Responsibility
    • Success Stories
    • News
    • Events
    • Locations
  • Therapeutic Areas
    • Oncology/Hematology
    • Neurology/Psychiatry
    • Endocrine/Metabolic
    • Inflammation/Immunology
    • Infectious Disease
      • COVID-19
    • Cardiovascular Disease
    • More Therapy Areas
  • Solutions
    • Biologics
      • Cell and Gene Therapies
    • Rare Diseases
      • Pediatric
    • Decentralized Trials
    • Full Service
      • Clinical Trial Planning
      • Clinical Trial Conduct
      • Regulatory Submission
    • Natural History Trials
  • Services
    • Regulatory Writing
    • Strategic Consulting
      • Statistical Power
    • Regulatory Affairs
      • Marketing Applications
      • Chemistry, Manufacturing, and Controls (CMC)
      • Agency Meetings
      • Regulatory Publishing
    • Clinical Operations
      • Monitoring & Site Management
      • Patient Recruitment
      • Patient Retention & Site Engagement
    • Medical Affairs
      • Medical Monitoring
    • Biometrics
    • Pharmacovigilance
    • Quality Assurance & Compliance
    • Resourcing/FSP
  • Knowledge Base
    • Library
    • Blog
    • Webinars
    • Podcasts
    • Success Stories
    • Newsletter
  • Contact Us
  • RFP
Home > Barbara balser biography

Barbara Balser, VMD

Veristat Thought Leader Biography

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

Contact Veristat Now


Request A Proposal

Contact Us


Balser_Barbara_websiteheadshot.jpg

Barbara Balser, VMD

Co-founder, Executive Vice President, Chief Scientific Officer

Barbara is one of the co-founders of Veristat, and presently acts as the Executive Vice-President and Chief Scientific Officer of the company. She has 30+ years of experience in the industry in the strategic consulting and reporting of clinical studies. She is involved in scientific oversight of projects from the development of protocol to the writing of clinical sections/summary documents of regulatory submissions including INDs/NDAs/BLAs/JNDAs. In her career, Barbara has contributed to 25+ marketing authorizations, and 10 publications!

Before founding Veristat, Balser practiced veterinary medicine and worked in clinical research.


Explore Related Services

  • Strategic Consulting
  • Regulatory Submissions
  • Medical Writing
Contact Us
Request A Proposal

Get Updates

  • Why Veristat
    • About Us
    • Our Approach
    • Success Stories
    • News
  • Therapeutic Areas
    • Oncology
    • Infectious Disease
    • Endocrine/Metabolic
    • CNS/Neurology
    • Cardiovascular Disease
    • More Therapy Areas
  • Solutions
    • Full Service
    • Strategic Resourcing
    • Cell and Gene Therapies
    • Decentralized Trials
    • Rare Diseases
  • Services
    • Strategic Consulting
    • Regulatory Affairs
      • Regulatory Approvals
      • Agency Meetings
      • Regulatory Publishing
    • Chemistry, Manufacturing, and Controls (CMC)
    • Clinical Operations
      • Monitoring & Site Management
      • Patient Recruitment
      • Patient Retention & Site Engagement
    • Medical Affairs
      • Medical Monitoring
      • Safety/Pharmacovigilance
    • Biometrics
      • Pharmacovigilance
  • Privacy Policy

  • ©2023 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.